Ironwood Pharmaceuticals, Inc. - Class A Common Stock (IRWD)
4.4700
-0.0000 (-0.00%)
NASDAQ· Last Trade: Jul 8th, 4:38 AM EDT
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's after-market session. The company's market cap stands at $2.0 million. Ironwood Pharmaceuticals (NASDAQ:IRWD)
Via Benzinga · July 7, 2026
Get insights into the top gainers and losers of Tuesday's after-hours session.chartmill.com
Via Chartmill · July 7, 2026
Ironwood (IRWD) Q1 2026 Earnings Call Transcript
Via The Motley Fool · June 1, 2026
Ironwood Pharmaceuticals (NASDAQ:IRWD) Crushes Q1 Estimates with 97% LINZESS Surgechartmill.com
Via Chartmill · May 7, 2026
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Reports Q4 Miss but Provides Robust 2026 Outlookchartmill.com
Via Chartmill · February 25, 2026
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Fits the Minervini High-Growth Momentum Trend Templatechartmill.com
Via Chartmill · January 30, 2026

This clinical-stage biotech focuses on developing therapies for neurological and immunoscience disorders.
Via The Motley Fool · March 23, 2026
Here are the top movers in Wednesday's session.chartmill.com
Via Chartmill · February 25, 2026

Ironwood (IRWD) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 25, 2026
Via MarketBeat · February 8, 2026
Via MarketBeat · January 7, 2026
Discover the most active stocks in Friday's session.chartmill.com
Via Chartmill · January 2, 2026
Friday's session: gap up and gap down stockschartmill.com
Via Chartmill · January 2, 2026
The company announced on Friday that it expects FY2026 revenue in the $450 million to $475 million range.
Via Stocktwits · January 2, 2026
What's going on in today's pre-market sessionchartmill.com
Via Chartmill · January 2, 2026
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · November 10, 2025
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · November 10, 2025
Via Benzinga · November 10, 2025
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · November 10, 2025
Via Benzinga · November 10, 2025
The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · November 10, 2025
Linzess is the first treatment approved for the disease in pediatric patients, the FDA said.
Via Stocktwits · November 5, 2025
Via Benzinga · September 30, 2025
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · September 30, 2025